Status:
UNKNOWN
Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric
Lead Sponsor:
Chinese Medical Association
Conditions:
Pediatrics
Dexmedetomidine
Eligibility:
All Genders
3-9 years
Phase:
PHASE4
Brief Summary
1. Acute Hemodynamic and respiratory Changes After Rapid Intravenous different doses of Dexmedetomidine in Pediatric. 2. Pharmacokinetics after a single Rapid Intravenous dose of Dexmedetomidine in Pe...
Eligibility Criteria
Inclusion
- selective operation of inguinal hernia repair、orthopedics operation or general surgery operation in children
- aged 3-9 years
- ASA I - II
- enter the operating room by himself without parents
- normal liver and kidney function
- no history of anesthesia medication allergy.
Exclusion
- allergic to dexmedetomidine, similar active ingredients or excipients
- G-6-PD deficiency
- a history of arrhythmia, bronchial and cardiovascular diseases, abnormal liver function and so on
- a history of use of alpha 2 receptor agonists or antagonists.
Key Trial Info
Start Date :
October 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT03337581
Start Date
October 20 2017
End Date
July 1 2019
Last Update
November 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China, 325027